The manufacture of medicines in a pharmacy

Federal Administrative Court on the Compounding of Medicinal Products in Pharmacies

In its judgment of 12 March 2026, the German Federal Administrative Court (BVerwG) clarified important issues concerning the compounding of medicinal products in pharmacies.

Dr. Oliver Stöckel analyses the decision in his latest article for GRUR-Prax. The article focuses on the requirements for prescriptions for medical practice supplies, the need to identify specific patients, and the limitation of stock preparations to a maximum of 100 patients or patient portions per day.

The decision is likely to significantly restrict the practical scope for compounding medicinal products for medical practice supplies.

Beck-Online subscribers can read the full article here.